Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence

Experimental and Clinical Psychopharmacology

Volumn 13, Issue 4, 2005, Pages 293-302

  Marsch, Lisa A ^a,b,d   Stephens, Mary Ann Chutuape ^a   Mudric, Timothy ^a   Strain, Eric C ^a   Bigelow, George E ^a   Johnson, Rolley E ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c RECKITT BENCKISER   (United Kingdom)

^d NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Buprenorphine; LAAM; Methadone; Opioid; Treatment

Indexed keywords

BUPRENORPHINE; COCAINE; LEVACETYLMETHADOL; METHADONE; OPIATE;

ADULT; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG INDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHADONE; METHADYL ACETATE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; RECEPTORS, OPIOID, MU; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 29444445834     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.13.4.293     Document Type: Article

References (49)

1. Agosti, V., Nunes, E., Stewart, J. W., & Quitkin, F. M. (1999). Patient factors related to early attrition from an outpatient cocaine research clinic. International Journal of the Addictions, 26, 327-334.
2. Alterman, A. L., Rutherford, M. J., Cacciola, J. S., McKaym, J. R., & Boardman, C. R. (1998). Prediction of 7 months methadone maintenance treatment response by four measures of antisociality. Drug and Alcohol Dependence, 49, 217-223.
3. Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment: Patients, programs, services and outcome. New York: Springer-Verlag.
4. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
5. Bendel, R. B., & Afifi, A. A. (1977). Comparison of stopping rules in forward stepwise regression. Journal of the American Statistical Association, 72, 46-53.
6. Bickel, W. K., & Amass, L. (1995). Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3, 477-489.
7. Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34, 791-806.
8. Derogatis, L. R. (1983). Administration, scoring and procedures manual-II. Towson, MD: Clinical Psychometric Research.
9. Dole, V. P. (1988). Implications of methadone maintenance for theories of narcotic addiction. Journal of the American Medical Association, 260, 3025-3029.
10. Dole, V. P., & Nyswander, M. E. (1965). A medical treatment for diacetyl morphine (heroin) addiction: A clinical trial with methadone hydrochloride. Journal of the American Medical Association, 193, 646-650.
11. Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118, 304-309.
12. Eissenberg, T., Bigelow, G. E., Strain, E. C., Walsh, S. L., Brooner, R. K., Stitzer, M. L., & Johnson, R. E. (1997). Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence: A randomized clinical trial. Journal of the American Medical Association, 277, 1945-1951.
13. Fiellin, D. A., & O'Connor, P. G. (2002). New federal initiatives to enhance the medical treatment of opioid dependence. Annals of Internal Medicine, 137, 688-692.
14. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured Clinical Interview for DSM-IV Axis 1 Disorders. New York: Department of Biometrics Research, New York State Psychiatric Institute.
15. Friedman, A. S., & Glickman, N. W. (1987). Effects of psychiatric symptomatology on treatment outcome for adolescent male drug users. Journal of Nervous and Mental Diseases, 175, 425-430.
16. Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., et al. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349, 949-958.
17. Glass, G. V., McGaw, B., & Smith, M. L. (1981). Meta-analysis in social research. Beverly Hills, CA: Sage.
18. Han, K., Weed, N. C., Calhoun, R. F., & Butcher, J. N. (1995). Psychometric characteristics of the MMP1-2 Cook-Medley Hostility Scale. Journal of Personality Assessment, 65(Suppl. 3), 567-585.
19. Helmus, T. C., Downey, K. K., Arfken, C. L., Henderson, M. J., & Schuster, C. R. (2001). Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users. Drug and Alcohol Dependence, 61, 287-295.
20. Hser, Y., Anglin, M. D., & Liu, Y. (1990-91). A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. International Journal of the Addictions, 25, 1295-1315.
21. Hunter, J. E., & Schmidt, F. L. (1990). Methods of meta-analysis. Newbury Park, CA: Sage.
22. Jasinski, D. R., Pevnick, J. S., & Griffith, J. D. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Archives of General Psychiatry, 35, 501-516.
23. Joe, G. W., Brown, B. S., & Simpson, D. D. (1995). Psychological problems and client engagement in methadone treatment. Journal of Nervous and Mental Disease. 183, 704-710.
24. Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290-1297.
25. Johnson, R. E., Jaffe, J. H., & Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. Journal of the American Medical Association, 267, 2750-2755.
26. Leshner, A. I. (1998). Addiction is a brain disease, and it matters. Science, 278, 45-47.
27. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S. Jr., Kintaudi, P., et al. (1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter randomized clinical trial. Addiction, 93, 475-478.
28. Ling, W., Charuvastra, V. C., Kaim, S. C., & Klett, C. J. (1976). Methadyl acetate and methadone as maintenance treatments for heroin addicts. A Veterans Administration cooperative study. Archives of General Psychiatry, 33, 709-720.
29. Magura, S., Nwakeze, P. C., & Demsky, S. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51-60.
30. Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: A meta-analysis. Addiction, 93, 515-532.
31. McCormick, R., & Smith, M. (1995). Aggression and hostility in substance abusers: The relationship to abuse patterns, coping style, and relapse triggers. Addictive Behaviors, 20(Suppl. 5), 555-562.
32. McLellan, A. T. (1983). Patient characteristics associated with outcome. In J. R. Cooper, F. Altman, B. S. Brown, & D. Czechowicz (Eds.). Research on the treatment of drug addiction: State of the art (NIDA Research Monograph Series Publication No. ADM 83-1281). Washington, DC: U.S. Government Printing Office.
33. McLellan, A. T., Luborsky, L., O'Brien, C. P., Barr, H. L., & Evans, F. (1986). Alcohol and drug abuse treatment in three different populations: Is there improvement and is it predictable? American Journal of Drug and Alcohol Abuse, 12, 101-120.
34. McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Diseases, 168, 26-33.
35. McLellan, A. T., Luborsky, L., Woody, G. E., O'Brien, C. P., & Druley, K. A. (1983). Predicting response to drug and alcohol treatment: Role of psychiatric severity. Archives of General Psychiatry, 40, 620-625.
36. Pedhazer, E. J. (1982). Multiple regression in behavioral research. Fort Worth, TX: Harcourt Brace.
37. Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance-Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000). Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction, 95, 219-228.
38. Petry, N. M., & Bickel, W. K. (1999). Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatric Services, 50, 219-227.
39. Petry, N. M., & Bickel, W. K. (2000). Gender differences in hostility of opioid-dependent outpatients: Role in early treatment termination. Drug and Alcohol Dependence, 58, 27-33.
40. Rounsaville, B. J., Kosten, T. R., Weissman, M. M., & Kleber, H. D. (1986). Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Archives of General Psychiatiy. 43(Suppl. 8), 739-745.
41. Saxon, A. J., Wells, E. A., Fleming, C., Jackson, T. R., & Calsyn, D. A. (1996). Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction, 91, 1197-1209.
42. Schottenfeld, R. S., Pakes, J. R., Oliveto, A., Zeidonis, D., & Kosten, T. R. (1997). Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry, 54, 713-720.
43. Silverman, K., Chutuape, M. A., Bigelow, G. E., & Stitzer, M. L. (1999). Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude. Psychopharmacology, 146, 128-138.
44. Silverman, K., Higgins, S. T., Brooner, R. K., Montoya, I. D., Cone, E. J., Schuster, C. R., & Preston, K. L. (1996). Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Archives of General Psychiatry, 53, 409-415.
45. Silverman, K., Wong, C. J., Umbricht-Schneiter, A., Montoya, I. D., Schuster, C. R., & Preston, K. L. (1998). Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. Journal of Consulting and Clinical Psychology, 66, 811-824.
46. Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993). Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine, 119, 23-27.
47. Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1998). Useful predictors of outcome in methadone-treated patients: Results from a controlled clinical trial with three doses of methadone. Journal of Maintenance in the Addictions, 1, 15-28.
48. Wasserman, D. A., Stewart, A. L., & Delucchi, K. L. (2001). Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug and Alcohol Dependence, 65, 65-75.
49. Woody, G. E., McLellan, A. T., Luborsky, L., & O'Brien, C. P. (1995). Psychotherapy in community methadone programs: A validation study. American Journal of Psychiatry, 152, 1302-1308.